Riskpilot← Back to searchSign inGet full accessSackemark Läkare AB
ABActiveOrg 5565171963Åkervägen 12General medical practice activities · NACE 8621Est. 19950 employees
Revenue 2025
SEK 0
EBITDA margin
—
+48% vs 2024
Equity ratio
79.7%
Financial strength
Net profit 2025
SEK -11K
+96% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -11K | +48% |
| Net profit | SEK -11K | +96% |
| Total assets | SEK 64K | -35% |
| Equity | SEK 51K | -18% |
| Employees | 0 | — |
Legal name
Sackemark Läkare AB
Org number
5565171963
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
16 september 1995
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva vård, behandling, undervisning, utbildning och forskning för människor i beroendetillstånd, allmän medicin och medicinsk forskning, vetenskapliga och medicinska tjänster, instruktion av människor, behandlings- tjänster och utgivning av böcker, spel och leksaker, handel med värdepapper, antikviteter och möbler, häst och travsport samt därmed förenlig verksamhet.
Address
Åkervägen 12
Phone
+46740418529
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 620 | 1 227 | 36 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 614 | 304 | −77 | −21 | −11 |
| Depreciation & amort. | −60 | −0 | −0 | −0 | −0 |
| EBIT | 554 | 304 | −77 | −21 | −11 |
| Net financials | — | — | −3 598 | −598 | −1 |
| Profit before tax | 791 | 414 | −1 737 | −301 | −11 |
| Tax | −179 | −97 | −15 | −0 | −0 |
| Net profit | 612 | 317 | −1 752 | −301 | −11 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 579 | 2 142 | 144 | 99 | 64 |
| Equity | 1 877 | 1 694 | 63 | 62 | 51 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 436 | 291 | 65 | 37 | 14 |
| Total debt | 436 | 291 | 65 | 37 | 14 |
EBITDA margin
-1100000.0%
This company
15.8%
Market median
-6962125% vs market
20212025
Equity ratio
79.7%
This company
38.2%
Market median
+109% vs market
20212025
Return on equity
-21.6%
This company
18.4%
Market median
-217% vs market
20212025
Net profit margin
-1100000.0%
This company
8.1%
Market median
-13580347% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.25×
This company
0.62×
Market median
+60% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
PB Chief Auditor | Chief Auditor | 2022 – 2024 |
UG Chief Auditor | Chief Auditor | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Deputy Board Member | 2020 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Sackemark Läkare AB 
West-Base ABBoard members of Sackemark Läkare AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Peter Bo Weine Karlsson | Chief Auditor | 0 companies |
| Ulf Greger Johansson Längvik | Chief Auditor | 0 companies |
| Hans Stefan Sackemark | Chairman | 0 companies |
| Eva Susanne Sackemark | Deputy Board Member | 0 companies |
| Björn Alexander Sackemark | Board of Directors | 0 companies |